at day 8, the placebo-adjusted least squares mean (95% confidence interval) percent change from baseline in body weight was 0.8% (0.02, 1.56) with 0.5 mg of CT-388, 0.8% (1.50, 0.01) with 2 mg of CT-388, 1.3% (2.03, 0.53) with 5 mg of CT-388, 1.6% (2.36, 0.83) with 6 mg of CT-388, and 3.1% (3.92, 2.37) with 7.5 mg of CT-388
Peptide solutions are much less stable than powders
By understanding the relationship between glutathione and metformin, we can make informed decisions that support our health
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial